Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PROCEPT BioRobotics (PRCT) Interest & Investment Income (2020 - 2025)

Historic Interest & Investment Income for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to $2.7 million.

  • PROCEPT BioRobotics' Interest & Investment Income rose 412.65% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year increase of 807.26%. This contributed to the annual value of $9.4 million for FY2024, which is 2912.77% up from last year.
  • As of Q3 2025, PROCEPT BioRobotics' Interest & Investment Income stood at $2.7 million, which was up 412.65% from $3.5 million recorded in Q2 2025.
  • In the past 5 years, PROCEPT BioRobotics' Interest & Investment Income registered a high of $3.6 million during Q1 2025, and its lowest value of -$77000.0 during Q4 2021.
  • Over the past 5 years, PROCEPT BioRobotics' median Interest & Investment Income value was $1.3 million (recorded in 2023), while the average stood at $1.5 million.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first crashed by 32857.14% in 2022, then soared by 139833.33% in 2023.
  • PROCEPT BioRobotics' Interest & Investment Income (Quarter) stood at -$77000.0 in 2021, then surged by 1388.31% to $992000.0 in 2022, then skyrocketed by 220.36% to $3.2 million in 2023, then plummeted by 42.64% to $1.8 million in 2024, then skyrocketed by 48.11% to $2.7 million in 2025.
  • Its Interest & Investment Income stands at $2.7 million for Q3 2025, versus $3.5 million for Q2 2025 and $3.6 million for Q1 2025.